Smad 3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice

JINGSONG ZHAO,1* WEI SHI,2* YAN-LING WANG,1 HUI CHEN,1 PABLO BRINGAS, JR.,1 MICHAEL B. DATTO,3 JOSHUA P. FREDERICK,3 XIAO-FAN WANG,3 AND DAVID WARBURTON2 1Center for Craniofacial Molecular Biology, University of Southern California, Los Angeles 90033; 2Departments of Surgery and Pediatrics, and the Cell and Developmental Biology Program, The Childrens Hospital Los Angeles Research Institute, Los Angeles, California 90027; and 3Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina 27710

[1]  R. Kucherlapati,et al.  Functional Characterization of Transforming Growth Factor β Signaling in Smad2- and Smad3-deficient Fibroblasts* , 2001, The Journal of Biological Chemistry.

[2]  D. Warburton,et al.  Smad7 and Smad6 Differentially Modulate Transforming Growth Factor β-induced Inhibition of Embryonic Lung Morphogenesis* , 2000, The Journal of Biological Chemistry.

[3]  A. Ghosh,et al.  Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-β involves functional cooperation with p300/CBP transcriptional coactivators , 2000, Oncogene.

[4]  Cooper Ja.  Pulmonary fibrosis: pathways are slowly coming into light. , 2000, American journal of respiratory cell and molecular biology.

[5]  A. Roberts,et al.  Loss of Smad3 modulates wound healing. , 2000, Cytokine & growth factor reviews.

[6]  G. Hunninghake,et al.  NHLBI Workshop Summary. Pharmacological therapy for idiopathic pulmonary fibrosis. Past, present, and future. , 1999, American journal of respiratory and critical care medicine.

[7]  Anita B. Roberts,et al.  Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response , 1999, Nature Cell Biology.

[8]  Qingjian Wang,et al.  Reduction of bleomycin induced lung fibrosis by transforming growth factor β soluble receptor in hamsters , 1999, Thorax.

[9]  K. Miyazono,et al.  Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. , 1999, The Journal of clinical investigation.

[10]  X. F. Wang,et al.  Targeted Disruption of Smad3 Reveals an Essential Role in Transforming Growth Factor β-Mediated Signal Transduction , 1999, Molecular and Cellular Biology.

[11]  A. Roberts,et al.  Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF‐β , 1999, The EMBO journal.

[12]  A. Roberts,et al.  SMAD3/4-dependent transcriptional activation of the human type VII collagen gene (COL7A1) promoter by transforming growth factor beta. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[13]  H. Lodish,et al.  Synergistic cooperation of TFE3 and smad proteins in TGF-beta-induced transcription of the plasminogen activator inhibitor-1 gene. , 1998, Genes & development.

[14]  J. Graff,et al.  Smad3 Mutant Mice Develop Metastatic Colorectal Cancer , 1998, Cell.

[15]  C. Deng,et al.  Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor smad2. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[16]  A. Roberts,et al.  Smad-dependent Transcriptional Activation of Human Type VII Collagen Gene (COL7A1) Promoter by Transforming Growth Factor-β* , 1998, The Journal of Biological Chemistry.

[17]  G. Gurujeyalakshmi,et al.  Regulation of transforming growth factor-beta1 mRNA expression by taurine and niacin in the bleomycin hamster model of lung fibrosis. , 1998, American journal of respiratory cell and molecular biology.

[18]  D. Warburton,et al.  Abrogation of Smad3 and Smad2 or of Smad4 gene expression positively regulates murine embryonic lung branching morphogenesis in culture. , 1998, Developmental biology.

[19]  R. Braun,et al.  Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis. , 1997, Biochemical pharmacology.

[20]  K. Matsumoto,et al.  Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. A morphologic study. , 1997, American journal of respiratory and critical care medicine.

[21]  K. Csaky,et al.  Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. , 1997, The Journal of clinical investigation.

[22]  P. Opolon,et al.  Prevention of bleomycin-induced pulmonary fibrosis after adenovirus-mediated transfer of the bacterial bleomycin resistance gene. , 1997, The Journal of clinical investigation.

[23]  D. Warburton,et al.  Abrogation of transforming growth factor-beta type II receptor stimulates embryonic mouse lung branching morphogenesis in culture. , 1996, Developmental biology.

[24]  D. Danielpour,et al.  Regulation of alveolar macrophage transforming growth factor-beta secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat. , 1993, The Journal of clinical investigation.

[25]  D. Hyde,et al.  Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice. , 1993, Thorax.

[26]  D. Heinegård,et al.  Altered expression of small proteoglycans, collagen, and transforming growth factor-beta 1 in developing bleomycin-induced pulmonary fibrosis in rats. , 1993, The Journal of clinical investigation.

[27]  J. Kelley.  Cytokines of the lung. , 1992, The American review of respiratory disease.

[28]  M. Sporn,et al.  Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation , 1989, The Journal of experimental medicine.

[29]  J. Weissler.  Idiopathic pulmonary fibrosis: cellular and molecular pathogenesis. , 1989, American Journal of the Medical Sciences.

[30]  J. Lazo,et al.  Alterations in pulmonary mRNA encoding procollagens, fibronectin and transforming growth factor-beta precede bleomycin-induced pulmonary fibrosis in mice. , 1988, The Journal of pharmacology and experimental therapeutics.

[31]  J. Lazo,et al.  High dose continuous infusion of bleomycin in mice: a new model for drug-induced pulmonary fibrosis. , 1987, The Journal of pharmacology and experimental therapeutics.

[32]  J. Seyer,et al.  Profiles of steady state levels of messenger RNAs coding for type I procollagen, elastin, and fibronectin in hamster lungs undergoing bleomycin-induced interstitial pulmonary fibrosis. , 1985, The Journal of clinical investigation.

[33]  D. Hyde,et al.  Morphometric estimates of infiltrative cellular changes during the development of bleomycin-induced pulmonary fibrosis in hamsters. , 1983, The American journal of pathology.

[34]  B. Mccarthy,et al.  DNA sequence analysis of a mouse pro alpha 1 (I) procollagen gene: evidence for a mouse B1 element within the gene , 1982, Molecular and cellular biology.

[35]  H. Stegemann,et al.  Determination of hydroxyproline. , 1967, Clinica chimica acta; international journal of clinical chemistry.

[36]  S. J. Chen,et al.  Interaction of smad3 with a proximal smad-binding element of the human alpha2(I) procollagen gene promoter required for transcriptional activation by TGF-beta. , 2000, Journal of cellular physiology.

[37]  C. Heldin,et al.  Specificity, diversity, and regulation in TGF-beta superfamily signaling. , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  S. J. Chen,et al.  Stimulation of type I collagen transcription in human skin fibroblasts by TGF-beta: involvement of Smad 3. , 1999, The Journal of investigative dermatology.

[39]  D. Madtes,et al.  Transforming growth factor-alpha deficiency reduces pulmonary fibrosis in transgenic mice. , 1999, American journal of respiratory cell and molecular biology.

[40]  J. Massagué.  TGF-beta signal transduction. , 1998, Annual review of biochemistry.

[41]  K. Miyazono,et al.  TGF-beta signalling from cell membrane to nucleus through SMAD proteins. , 1997, Nature.

[42]  W. Border,et al.  Transforming growth factor beta in tissue fibrosis. , 1994, The New England journal of medicine.